Reshape Lifesciences Inc 1001 Calle Amanecersan Clemente Ca 92673 Pma Numberp160001 Supplement Numbers047 Date Received01 19 2022 Decision Date07 18 2022 Product Code Lti Advisory Committee Gastroenterology Urology Supplement Typenormal 180 Day Track No User Fee Supplement Reason Labeling Change Pas Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Reshape Lifesciences Inc 1001 Calle Amanecersan Clemente Ca 92673 Pma Numberp160001 Supplement Numbers047 Date Received01 19 2022 Decision Date07 18 2022 Product Code Lti Advisory Committee Gastroenterology Urology Supplement Typenormal 180 Day Track No User Fee Supplement Reason Labeling Change Pas Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA P160001S047 ReShape Lifesciences, Inc.1001 Calle Amanecersan Clemente, CA 92673 PMA NumberP160001 Supplement NumberS047 Date Received01/19/2022 Decision Date07/18/2022 Product Code LTI  Advisory Committee Gastroenterology/Urology Supplement Typenormal 180 Day Track No User Fee Supplement Reason Labeling Change - Pas Expedited Review Granted? No	Obalon Balloon System	2022-07-18